AI assistant
VOLITIONRX LTD — Director's Dealing 2024
Jun 4, 2024
34395_dirs_2024-06-04_6538162b-5b44-46b0-bbbc-08025bc7b31c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2024-06-01-05:00
Reporting Person: Kway Jasmine (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-01-05:00 | Common Stock | A | 13570 | — | Acquired | 118485 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10400 | Indirect |
Footnotes
F1: On June 1, 2024, the reporting person was awarded 13,570 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,524 units, 4,523 units, and 4,523 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.